Aldeyra

Yahoo Finance • 21 hours ago

Bragar Eagel & Squire, P.C. Is Investigating TechTarget and Aldeyra and Encourages Investors to Contact the Firm

NEW YORK, April 15, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against TechTarget, Inc. (NASDAQ:TTGT) and Aldeyra Therapeutics, Inc. (NASDA... Full story

Yahoo Finance • yesterday

ALDX INVESTIGATION NOTICE: Suffer Losses on Aldeyra Therapeutics, Inc.? Contact BFA Law about the Securities Investigation (NASDAQ:ALDX)

NEW YORK, April 15, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) for potential violations of the federal securities laws. If yo... Full story

Yahoo Finance • 3 days ago

ALDX STOCK REMINDER: The Aldeyra Therapeutics, Inc. Investigation is Ongoing – Investors are Urged to Contact BFA Law (NASDAQ:ALDX)

NEW YORK, April 13, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) for potential violations of the federal securities laws. If yo... Full story

Yahoo Finance • 5 days ago

Aldeyra Therapeutics, Inc. (ALDX) Faces Scrutiny After Stock Drops 70% On FDA’s Reproxalap Complete Response Letter – Hagens Berman

SAN FRANCISCO, April 11, 2025 (GLOBE NEWSWIRE) -- On April 3, 2025 investors in Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) saw the price of their shares crash over 70% after the company announced that it received a Complete Response Lette... Full story

Yahoo Finance • 5 days ago

ALDX STOCK NOTIFICATION: Did Aldeyra Therapeutics, Inc. Violate the Securities Laws? Investors are Notified to Contact BFA Law (NASDAQ:ALDX)

NEW YORK, April 11, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) for potential violations of the federal securities laws. If yo... Full story

Yahoo Finance • 6 days ago

ALDEYRA ALERT: Bragar Eagel & Squire, P.C. is Investigating Aldeyra Therapeutics, Inc. on Behalf of Aldeyra Stockholders and Encourages Investors to Contact the Firm

NEW YORK, April 10, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Aldeyra Therapeutics, Inc. (“Aldeyra” or the “Company”) (NASDAQ:ALDX... Full story

Yahoo Finance • 7 days ago

ALDX CLASS NOTICE: An Investigation has been Initiated on behalf of Aldeyra Therapeutics, Inc. Investors -- Contact BFA Law if You Lost Money (NASDAQ:ALDX)

NEW YORK, April 09, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) for potential violations of the federal securities laws. If yo... Full story

Yahoo Finance • 9 days ago

ALDX SECURITIES REPORT: Aldeyra Therapeutics, Inc. Securities Investigation Could Allow Investors to Recover Losses; Contact BFA Law (NASDAQ:ALDX)

NEW YORK, April 07, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) for potential violations of the federal securities laws. If yo... Full story

Yahoo Finance • 11 days ago

ALDX SECURITIES ALERT: Aldeyra Therapeutics, Inc. Investors are Notified of the Ongoing Securities Investigation; Contact BFA Law (NASDAQ:ALDX)

NEW YORK, April 05, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) for potential violations of the federal securities laws. If yo... Full story

Yahoo Finance • 12 days ago

Kirby McInerney LLP Announces Investigation of Possible Claims Against Aldeyra Therapeutics, Inc. (ALDX) on Behalf of Investors

NEW YORK, April 04, 2025 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP is investigating potential claims against Aldeyra Therapeutics, Inc. (“Aldeyra” or the “Company”) (NASDAQ:ALDX). The investigation concerns whether Aldeyra... Full story

Yahoo Finance • 12 days ago

INVESTOR ALERT: Investigation of Aldeyra Therapeutics, Inc. (ALDX) Announced by Holzer & Holzer, LLC

ATLANTA, April 04, 2025 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC is investigating whether Aldeyra Therapeutics, Inc. (“Aldeyra” or the “Company”) (NASDAQ: ALDX) complied with federal securities laws. On April 3, 2025, Aldeyra announced i... Full story

Yahoo Finance • 13 days ago

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Aldeyra Therapeutics, Inc. – ALDX

NEW YORK, April 03, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Aldeyra Therapeutics, Inc. (“Aldeyra” or the “Company”) (NASDAQ: ALDX). Such investors are advised to contact Danielle Peyton at... Full story

Yahoo Finance • 13 days ago

ALDX BREAKING NEWS: Aldeyra Therapeutics, Inc. 75% Stock Drop Triggers Securities Investigation; Contact BFA Law if You Lost Money (NASDAQ:ALDX)

NEW YORK, April 03, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) for potential violations of the federal securities laws. If yo... Full story

Yahoo Finance • 13 days ago

BREAKING: Block & Leviton Investigating Aldeyra Therapeutics (ALDX) For Securities Fraud After Shares Fall Nearly 75%; Investors Encouraged to Contact the Firm

BOSTON, April 03, 2025 (GLOBE NEWSWIRE) -- Block & Leviton is investigating Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) for potential securities law violations. Investors who have lost money in their Aldeyra Therapeutics, Inc. investment s... Full story

Yahoo Finance • 2 months ago

Aldeyra, UnitedHealth Group Incorporated, Blue Ridge Bankshares, and Amplitude Investigation Alert: Johnson Fistel, LLP Encourages Long-Term Investors to Reach Out for More Information

SAN DIEGO, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Shareholder rights law firm Johnson Fistel, LLP, investigates potential violations of federal and state laws by certain officers of the companies of Aldeyra Therapeutics, Inc. (NASDAQ: ALDX),... Full story

Yahoo Finance • last year

Aldeyra Therapeutics Enters into Exclusive Option Agreement with AbbVie for License to Develop and Commercialize Reproxalap

LEXINGTON, Mass., November 01, 2023--(BUSINESS WIRE)--Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat immune-mediated diseases, today... Full story

Yahoo Finance • 2 years ago

Lifshitz Law PLLC Announces Investigations of Aldeyra Therapeutics, Inc. (NASDAQ: ALDX), Verizon Communications, Inc. (NYSE: VZ), Eos Energy Enterprises, Inc. (NASDAQ: EOSE), and Hayward Holdings, Inc. (NYSE: HAYW)

NEW YORK, Sept. 30, 2023 (GLOBE NEWSWIRE) -- Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) Lifshitz Law PLLC announces investigation into possible securities laws violations and/or breaches of fiduciary duties in connection with allegation... Full story

Yahoo Finance • 2 years ago

SHAREHOLDER ALERT: Levi & Korsinsky Notifies Aldeyra Therapeutics, Inc. (ALDX) Investors of a Class Action Lawsuit and Upcoming Deadline

NEW YORK, Sept. 29, 2023 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Aldeyra Therapeutics, Inc. ("Aldeyra" or the "Company") (NASDAQ: ALDX) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to... Full story

Yahoo Finance • 2 years ago

SHAREHOLDER ALERT: The Law Offices of Vincent Wong Remind Aldeyra Investors of a Lead Plaintiff Deadline of September 29, 2023

NEW YORK, Sept. 28, 2023 (GLOBE NEWSWIRE) -- Attention Aldeyra Therapeutics, Inc. ("Aldeyra") (NASDAQ: ALDX) shareholders: The Law Offices of Vincent Wong announce that a class action lawsuit has commenced on behalf of investors who pur... Full story

Yahoo Finance • 2 years ago

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Aldeyra Therapeutics, Inc. (ALDX)

LOS ANGELES, Sept. 27, 2023 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming September 29, 2023 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purcha... Full story